Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MALL pseudogene 1 (MALLP1) represents a non-functional, processed pseudogene derived from the parental MALL (MAL-like) gene, which is part of the MAL family of integral membrane proteins. Pseudogenes result from mutations, frame shifts, or retrotransposition events that disable their protein-coding ability. Most pseudogenes, including MALLP1, do not encode translatable or functional proteins and are not recognized as therapeutic targets. While some pseudogenes have regulatory roles at the RNA level (such as acting as microRNA sponges or modulators of their parental gene’s expression), there is no evidence that MALLP1 is functionally relevant or druggable. MALLP1 is generally excluded from therapeutic target databases and is not used as a biomarker or clinical target. The MALL protein itself is an integral membrane protein and part of the MARVEL domain-containing superfamily. However, MALLP1 specifically designates an inactive, non-coding pseudogene. Some pseudogenes in general can modulate gene expression or miRNA pathways, but these effects are highly context-dependent and as yet undocumented for MALL pseudogene 1. There are no known drugs, mechanisms of action, or safety concerns related to MALLP1. MALLP1 should not be confused with the functional “MAL-like protein” or other true protein-coding gene family members.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MALL pseudogene 1 (MALLP1).